Notably, the mutations of TP53 gene occur in about 50% of non-small cell lung cancer (NSCLC) and TP53 mutation is associated with worse prognosis with treatment resistance19, therefore the prediction of TP53 mutation is also helpful for the diagnosis of lung cancer. This evidence concerns the gene TP53 and lung cancer.